	US 11,890,299 B2
	Ablation agent and methods of use
Victor Manuel Solano Umaña, Alajuela (CR); and Estefania Alvarez, Watertown, MA (US)
Assigned to Hologic, Inc., Marlborough, MA (US)
Filed by HOLOGIC, INC., Marlborough, MA (US)
Filed on May 29, 2020, as Appl. No. 16/888,499.
Claims priority of provisional application 62/867,753, filed on Jun. 27, 2019.
Prior Publication US 2020/0405382 A1, Dec. 31, 2020
Int. Cl. A61K 33/242 (2019.01); A61K 9/00 (2006.01); A61K 9/14 (2006.01); A61M 21/00 (2006.01); A61P 41/00 (2006.01); A61B 18/00 (2006.01); A61M 31/00 (2006.01)

CPC A61K 33/242 (2019.01) [A61K 9/0034 (2013.01); A61K 9/14 (2013.01); A61M 31/00 (2013.01); A61P 41/00 (2018.01); A61B 2018/0063 (2013.01); A61B 2018/00559 (2013.01); A61B 2018/00577 (2013.01); A61B 2218/007 (2013.01); A61M 2210/1433 (2013.01)]

18 Claims

1. A method of ablating a target body tissue, comprising:

applying an agent comprising HAuCl₄to the target body tissue, wherein the HAuCl₄has a molecular size greater than 50 microns, and,

removing the agent from the target tissue after ablation of the target tissue begins.